Subclinical atherosclerosis in patients with hidradenitis suppurativa treated with TNF inhibitors.
Muazzez Çiğdem ObaOzge AskinMehmet Guven GunverGokce KocaarslanDeniz Can AlisBurhan EnginPublished in: Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI) (2023)
Small sample size is limitation of the current study. Our study shows that patients with Hurley stage II and III HS undergoing TNF inhibitor therapy are under risk for progression of subclinical atherosclerosis.